Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients
NCT ID: NCT01733797
Last Updated: 2015-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
71 participants
INTERVENTIONAL
2012-12-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynasplint Therapy for Trismus in Head and Neck Cancer
NCT00507208
Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus
NCT05671861
Exercise Therapy and Jaw-Mobilizing Device for Trismus in Head and Neck Cancer Patients
NCT06719388
Prevention of Trismus During Radiotherapy and Quality of Life in Head and Neck Cancer Patients
NCT01354548
Effects of Exercise Therapy Adjuvant Device on Head and Neck Cancer Patients in the Treatment of Cancer Therapy Induced Trismus
NCT04740216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The use of jaw exercises using a Therabite appliance following treatment has been shown to reduce the level of Trismus in small studies. Many UK centres, however, use stacked wooden spatulas inserted between the incisors as a means of passive exercise. There is anecdotal evidence that suggests the use of exercises prior to treatment may help reduce the severity of the Trismus experienced by the patient.
This study will enrol 112 head and neck cancer patients allocated by chance to use either the Therabite or wooden spatula and patients will be asked to perform mouth exercises on a daily basis for 6 months.
There is a need to evaluate both the clinical effectiveness and cost-effectiveness of Therabite as opposed to wooden spatulas to determine whether they should be adopted as standard care in head and neck cancer patients.
In this pilot trial, the investigators will measure benefits of Therabite to patients, as compared to usual care with wooden spatulas. Mouth opening will be the key outcome for the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wooden spatula
Wooden spatula
Lollipop sticks placed between incisors
Therabite
Therabite
Hand held device placed in mouth that exercises the jaw
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wooden spatula
Lollipop sticks placed between incisors
Therabite
Hand held device placed in mouth that exercises the jaw
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years and older
* Able to read and write English sufficiently to be able to complete questionnaires
* Stage 3/4 oral and oropharyngeal cancer patients undergoing:
Primary chemoradiotherapy or Surgical free flap plus post operative radiotherapy or post operative chemoradiotherapy
* All patients will receive 60-70 Gy in 30-35 fractions over 6 to 7 weeks to the region of the pterygoid muscles.
* All patients will have at least some trismus as indicated by subjective tightening in the jaw.
Exclusion Criteria
* Anatomically unable to use Therabite for example patients who may only be partially dentate and to use the Therabite would place extreme stress on the existing teeth
* Cognitive impairment as judged by the clinicians
* International patients treated who will not have routine UK follow up.
* Previous surgery or RT to the head and neck prior to this diagnosis
* Any patient who has no subjective tightening of the jaw.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Christie NHS Foundation Trust
OTHER
Brynn Chappell
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brynn Chappell
Clinical Trials Project Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof Slevin
Role: STUDY_CHAIR
The Christie NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth Hospital
Birmingham, , United Kingdom
Queen Victoria Hospital
East Grinstead, , United Kingdom
Aintree University Hospitals NHS Foundation Trust
Liverpool, , United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
York Hospital
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lee R, Molassiotis A, Rogers SN, Edwards RT, Ryder D, Slevin N. Protocol for the trismus trial-therabite versus wooden spatula in the amelioration of trismus in patients with head and neck cancer: randomised pilot study. BMJ Open. 2018 Mar 30;8(3):e021938. doi: 10.1136/bmjopen-2018-021938.
Lee R, Yeo ST, Rogers SN, Caress AL, Molassiotis A, Ryder D, Sanghera P, Lunt C, Scott B, Keeley P, Edwards RT, Slevin N. Randomised feasibility study to compare the use of Therabite(R) with wooden spatulas to relieve and prevent trismus in patients with cancer of the head and neck. Br J Oral Maxillofac Surg. 2018 May;56(4):283-291. doi: 10.1016/j.bjoms.2018.02.012. Epub 2018 Mar 9.
Related Links
Access external resources that provide additional context or updates about the study.
Christie NHS website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISRCTN79084153
Identifier Type: REGISTRY
Identifier Source: secondary_id
PB-PG-0610-22317
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
09DOG0843
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.